Lexaria Bioscience Overview

Lexaria Bioscience Cost of Revenue

Cost of Revenue analysis for LEXX.

Quarterly Cost of Revenue

$26568.00

As of Feb 28, 2026

Annual Cost of Revenue (TTM)

$72163.00

↑ 305.55% YoY

Trailing 12 months ending Feb 28, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin